Navigation Links
DNDi welcomes the Global Health Innovative Technology Fund (GHIT)

[Tokyo, Japan, and Geneva, Switzerland 8 April 2013] The Drugs for Neglected Diseases initiative (DNDi), based in Geneva, Switzerland, and DNDi Japan, based in Tokyo, welcome the launch of the Global Health Innovative Technology Fund (GHIT), an initiative supported by the Japanese government, several Japanese pharmaceutical companies, and the Bill & Melinda Gates Foundation.

The GHIT fund will support and stimulate research & development (R&D) projects for neglected diseases by leveraging scientific resources and expertise of the pharmaceutical industry in Japan, facilitating the collaboration between product development partnerships (PDPs), Japanese pharmaceutical companies, and the public sector, including universities and research institutes. GHIT now adds to the efforts of the past decade to accelerate innovation for diseases that affect the poorest of the poor in developing countries.

'This initiative comes at a time when the R&D landscape for neglected diseases is particularly in need of resources to guarantee that R&D is boosted in the long-term and that patients gain access to the fruits of that research', said Dr Bernard Pcoul, Executive Director of the Drugs for Neglected Diseases initiative (DNDi). 'We are delighted about the GHIT initiative', he added.

Since 2003, DNDi has actively collaborated with various public and private partners in Japan, including the University of Tokyo for the development of Ascofuranone for sleeping sickness and for establishing a research centre on visceral leishmaniasis in Bangladesh; the Kitasato Institute for screening of natural substances and establishing a pan-Asian screening network; and more recently with the pharmaceutical companies Eisai Ltd., to develop a pro-drug of ravuconazole for Chagas disease currently in clinical stage, and Astellas Pharma for drug discovery for sleeping sickness, leishmaniasis, and Chagas disease.

'We congratulate the GHIT founding partners for this excellent initiative and we aim to both continue and renew our fruitful partnerships in Japan to develop new treatments for neglected diseases, including sleeping sickness, leishmaniasis, Chagas disease, filarial infections, and paediatric HIV', said Professor Haruki Yamada, Chairman of the Board, DNDi Japan.


Contact: Violaine Dällenbach
Drugs for Neglected Diseases Initiative

Related medicine news :

1. GSA welcomes National Hartford Centers of Gerontological Nursing Excellence
2. Be Present Welcomes Wanderlust Festival to Copper Mountain, Colorado
3. Concordia welcomes 4 new Vanier scholars
4. Minneapolis Heart Institute Foundation welcomes Europace publication of Optim™ lead insulation paper
5. Minneapolis Heart Institute Foundation welcomes Europace publication of Optim lead insulation paper
6. Dengue Vaccine Initiative welcomes latest progress in vaccine development
7. Concordia welcomes Banting fellows
8. Crittenton Hospital Medical Center in Rochester, MI Welcomes Two Certified Nurse Midwives (CNMs) from Women's Excellence in Midwifery
9. Hun School Welcomes M.V. Whitlow Jr. as New Head Lacrosse Coach
10. Valley Orthopedics Welcomes New Orthopedic Surgeon Specializing in Hip Procedures
11. Special Announcement: Nouvelle Welcomes New International Partner to its Compression Wear Distribution Team
Post Your Comments:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
Breaking Medicine Technology: